SHANGHAI, 23. Oktober 2023 /PRNewswire/ — Vom 20. bis 24. Oktober fand dem 2023 ESMO-Kongress in Madrid, Spanien, statt. LX-039, ein innovatives Anti-Tumor-Medikament, das von Luoxin Pharmaceuticals Group Stock Co., Ltd. (Luoxin Pharmaceutical) entwickelt wurde, wurde für eine…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.